Sam Chun Dang Stock Revenue
| 000250 Stock | KRW 98,000 9,500 10.73% |
Sam Chun Dang fundamentals help investors to digest information that contributes to Sam Chun's financial success or failures. It also enables traders to predict the movement of Sam Stock. The fundamental analysis module provides a way to measure Sam Chun's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sam Chun stock.
Sam |
Sam Chun Dang Company Revenue Analysis
Sam Chun's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Sam Chun Revenue | 167.27 B |
Most of Sam Chun's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sam Chun Dang is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Sam Chun Dang reported 167.27 B of revenue. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The revenue for all Republic of Korea stocks is notably lower than that of the firm.
Sam Chun Dang is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 171.18 Billion. Sam Chun totals roughly 167.27 Billion in revenue claiming about 98% of equities under Health Care industry.Sam Fundamentals
| Return On Equity | -0.1 | |||
| Return On Asset | -0.034 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | (0.11) % | |||
| Current Valuation | 1.27 T | |||
| Shares Outstanding | 21.41 M | |||
| Shares Owned By Insiders | 38.64 % | |||
| Shares Owned By Institutions | 6.11 % | |||
| Price To Earning | 18.27 X | |||
| Price To Sales | 4.13 X | |||
| Revenue | 167.27 B | |||
| Gross Profit | 93.78 B | |||
| EBITDA | (11.05 B) | |||
| Net Income | (10.36 B) | |||
| Cash And Equivalents | 49.09 B | |||
| Total Debt | 29.25 B | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 3.07 X | |||
| Cash Flow From Operations | (7.71 B) | |||
| Target Price | 62000.0 | |||
| Number Of Employees | 390 | |||
| Beta | 2.26 | |||
| Market Capitalization | 1.09 T | |||
| Total Asset | 346 B | |||
| Retained Earnings | 91.08 B | |||
| Working Capital | 78.88 B | |||
| Current Asset | 101.2 B | |||
| Current Liabilities | 22.32 B | |||
| Z Score | 22.2 | |||
| Annual Yield | 0 % | |||
| Net Asset | 346 B | |||
| Last Dividend Paid | 50.0 |
About Sam Chun Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sam Chun Dang's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sam Chun using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sam Chun Dang based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Sam Stock
Sam Chun financial ratios help investors to determine whether Sam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sam with respect to the benefits of owning Sam Chun security.